Found: 5
Select item for more details and to access through your institution.
Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033684
- By:
- Publication type:
- Article
High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 1, p. 104, doi. 10.1093/neuonc/nos272
- By:
- Publication type:
- Article
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas†.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 11, p. 1244, doi. 10.1093/neuonc/nor117
- By:
- Publication type:
- Article
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
- Published in:
- Annals of Neurology, 2011, v. 70, n. 1, p. 163, doi. 10.1002/ana.22360
- By:
- Publication type:
- Article
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 607, doi. 10.1007/s11060-011-0628-z
- By:
- Publication type:
- Article